Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Conditions
Pulmonary Arterial Hypertension
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ordensklinikum Linz, Linz, Austria
Contact: Study coordinator (Regina Steringer-Mascherbauer) · regina.steringer-mascherbauer@ordensklinikum.at · +437327676Contact: Principal Investigator (Regina Steringer-Mascherbauer)Medical University Vienna, Vienna, Austria
Contact: Principal Investigator (Irene Lang)Fakultní Nemocnice Olomouc, Olomouc, Czechia
Contact: Principal Investigator (Jan Přeček)Všeobecná fakultní nemocnice v Praze, Prague, Czechia
Contact: Principal Investigator (Pavel Jansa)Hôpital Bicêtre-- Assistance Publique Hopitaux de Paris, Paris, France
Contact: Principal Investigator (Olivier Sitbon)Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Contact: Principal Investigator (Marianne Riou)DRK Kliniken Berlin Westend, Berlin, Germany
Contact: Principal Investigator (Christian Opitz)University Hospital Carl Gustav Carus of Technical University Dresden, Dresden, Germany
Contact: Study coordinator (Michael Halank) · michael.halank@uniklinikum-dresden.de · +4935145813981Contact: Principal Investigator (Michael Halank)Universitätsmedizin Greifswald, Greifswald, Germany
Contact: Principal Investigator (Ralf Ewert)Gottsegen National Cardiovascular lnstitute, Budapest, Hungary
Contact: Principal Investigator (Olga Hajnalka Balint)Medical University of Szeged, Szeged, Hungary
Contact: Principal Investigator (Gergely Ágoston)Sapienza University of Rome, Rome, Italy
Contact: Principal Investigator (Roberto Badagliacca)John Paul II Hospital Krakow, Krakow, Poland
Contact: Principal Investigator (Grzegorz Kopeć)Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock, Poland
Contact: Principal Investigator (Marcin Kurzyna)Centro Hospitalar Lisboa Norte - Santa Maria University Hospital, Lisbon, Portugal
Contact: Study coordinator (Rui Miguel Freire Plácido) · rui.placido@chln.min-saude.pt · +351217805306Contact: Principal Investigator (Rui Miguel Freire Plácido)Emergency Institute for Cardiovascular Diseases Prof. Dr. C.C.Iliescu, Bucharest, Romania
Contact: Principal Investigator (Ioan Mircea Coman)Emergency Clinical County Hospital of Targu Mures, Târgu Mureş, Romania
Contact: Principal Investigator (Ioan Tilea)Hospital Clinic of Barcelona, Barcelona, Spain
Contact: Principal Investigator (Isabel Blanco Vich)Hospital Ramon y Cajal, Madrid, Spain
Contact: Principal Investigator (Jose Andres Tenes Mayen)